DE60205338D1 - Heterocyclische verbindungen und mittel, die die hirnfunktion verbessern und als wirkstoff diese verbindungen enthalten - Google Patents

Heterocyclische verbindungen und mittel, die die hirnfunktion verbessern und als wirkstoff diese verbindungen enthalten

Info

Publication number
DE60205338D1
DE60205338D1 DE60205338T DE60205338T DE60205338D1 DE 60205338 D1 DE60205338 D1 DE 60205338D1 DE 60205338 T DE60205338 T DE 60205338T DE 60205338 T DE60205338 T DE 60205338T DE 60205338 D1 DE60205338 D1 DE 60205338D1
Authority
DE
Germany
Prior art keywords
compounds
alkyl
agents
improve
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60205338T
Other languages
English (en)
Other versions
DE60205338T2 (de
Inventor
Seiichiro Kawashima
Toshiyuki Matsuno
Naoki Fukuda
Kenichi Saitoh
Yoshimasa Yamaguchi
Masaya Higashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zenyaku Kogyo KK
Original Assignee
Zenyaku Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zenyaku Kogyo KK filed Critical Zenyaku Kogyo KK
Publication of DE60205338D1 publication Critical patent/DE60205338D1/de
Application granted granted Critical
Publication of DE60205338T2 publication Critical patent/DE60205338T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE60205338T 2001-01-30 2002-01-30 Heterocyclische verbindungen und mittel, die die hirnfunktion verbessern und als wirkstoff diese verbindungen enthalten Expired - Lifetime DE60205338T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001022385 2001-01-30
JP2001022385 2001-01-30
PCT/JP2002/000694 WO2002060907A1 (fr) 2001-01-30 2002-01-30 Composes heterocycliques et compositions ameliorant les fonctions cerebrales contenant ces derniers comme principe actif

Publications (2)

Publication Number Publication Date
DE60205338D1 true DE60205338D1 (de) 2005-09-08
DE60205338T2 DE60205338T2 (de) 2006-06-01

Family

ID=18887808

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60205338T Expired - Lifetime DE60205338T2 (de) 2001-01-30 2002-01-30 Heterocyclische verbindungen und mittel, die die hirnfunktion verbessern und als wirkstoff diese verbindungen enthalten

Country Status (11)

Country Link
US (2) US7141579B2 (de)
EP (1) EP1357124B1 (de)
JP (1) JP4285994B2 (de)
KR (1) KR100850818B1 (de)
CN (1) CN100338074C (de)
AT (1) ATE301125T1 (de)
AU (1) AU2002230098B2 (de)
CA (1) CA2436589C (de)
DE (1) DE60205338T2 (de)
ES (1) ES2247304T3 (de)
WO (1) WO2002060907A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1357124B1 (de) * 2001-01-30 2005-08-03 Zenyaku Kogyo Kabushiki Kaisha Heterocyclische verbindungen und mittel, die die hirnfunktion verbessern und als wirkstoff diese verbindungen enthalten
EP1791833A2 (de) * 2004-09-24 2007-06-06 Allergan, Inc. 4-(kondensiertes cyclisches methyl)imidazol-2-thione, die als alpha2-adrenerge agonisten wirken
EP1797043A1 (de) * 2004-09-24 2007-06-20 Allergan, Inc. 4-(phenylmethyl und substituiertes phenylmethyl)imidazol-2-thione, die als spezifische alpha2-adrenerge agonisten wirken
US7348432B2 (en) 2004-10-27 2008-03-25 Janssen Phamaceutica N.V. Pyridine imidazoles and aza-indoles as progesterone receptor modulators
JP5089377B2 (ja) * 2005-03-11 2012-12-05 全薬工業株式会社 複素環式化合物を有効成分とする免疫抑制剤及び抗腫瘍剤
JP5160764B2 (ja) * 2006-10-13 2013-03-13 全薬工業株式会社 特定の構造の複素環化合物を含む抗鬱剤、脳保護剤、アミロイドβ沈着抑制剤または老化抑制剤
US20090221554A1 (en) * 2008-02-28 2009-09-03 Zenyaku Kogyo Kabushiki Kaisha Method of treating cognitive impairment
CN102438992A (zh) * 2008-12-15 2012-05-02 加利福尼亚大学董事会 诱导淀粉样前体蛋白裂解以形成新片段的方法
EP2413929A4 (de) * 2009-04-02 2012-10-10 Zenyaku Kogyo Co Ltd Verfahren zur behandlung von kognitiver beeinträchtigung
CN102395366A (zh) * 2009-04-14 2012-03-28 金·尼古拉斯·格林 降低前ADAM10分泌酶和/或β分泌酶水平的方法
US20100298348A1 (en) * 2009-05-11 2010-11-25 Kim Nicholas Green Method of Decreasing Ubiquitylated Protein Levels
EP2808021B1 (de) * 2012-01-25 2017-08-23 Tohoku University Mittel zur verbesserung der gehirnfunktion
GB201321736D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
CN106478638A (zh) * 2016-08-31 2017-03-08 安徽省鸿鑫生物科技有限公司 一种2‑羟基‑7‑甲基咪唑并[1,2‑a]嘧啶的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0774205B2 (ja) * 1986-12-04 1995-08-09 三井石油化学工業株式会社 新規イミダゾ−ル誘導体
JPH0670064B2 (ja) 1986-12-08 1994-09-07 三井石油化学工業株式会社 二環性イミダゾ−ル誘導体
EP0524055A1 (de) * 1991-07-19 1993-01-20 Synthelabo Imidazo(2,1-b)benzothiazolderivate, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung
US5464843A (en) 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
JPH0841065A (ja) 1994-07-29 1996-02-13 Sanwa Kagaku Kenkyusho Co Ltd 1−アザビシクロ[3.3.0]オクタン誘導体の製法
US6114334A (en) 1995-07-13 2000-09-05 Knoll Aktiengesellschaft Piperazine derivatives as therapeutic agents
CA2387719C (en) * 1999-07-30 2010-04-27 Zenyaku Kogyo Kabushiki Kaisha Azaindolizinone derivatives and cognitive enhancers comprising the same as effective components
EP1357124B1 (de) * 2001-01-30 2005-08-03 Zenyaku Kogyo Kabushiki Kaisha Heterocyclische verbindungen und mittel, die die hirnfunktion verbessern und als wirkstoff diese verbindungen enthalten
JP5160764B2 (ja) * 2006-10-13 2013-03-13 全薬工業株式会社 特定の構造の複素環化合物を含む抗鬱剤、脳保護剤、アミロイドβ沈着抑制剤または老化抑制剤
US20090221554A1 (en) * 2008-02-28 2009-09-03 Zenyaku Kogyo Kabushiki Kaisha Method of treating cognitive impairment

Also Published As

Publication number Publication date
US7767824B2 (en) 2010-08-03
US20060205742A1 (en) 2006-09-14
JP4285994B2 (ja) 2009-06-24
AU2002230098B2 (en) 2007-06-14
KR20030070145A (ko) 2003-08-27
WO2002060907A1 (fr) 2002-08-08
CN1531540A (zh) 2004-09-22
CA2436589A1 (en) 2002-08-08
EP1357124A4 (de) 2004-02-04
JPWO2002060907A1 (ja) 2004-11-11
CN100338074C (zh) 2007-09-19
EP1357124A1 (de) 2003-10-29
EP1357124B1 (de) 2005-08-03
CA2436589C (en) 2010-10-19
DE60205338T2 (de) 2006-06-01
US20040048879A1 (en) 2004-03-11
ATE301125T1 (de) 2005-08-15
US7141579B2 (en) 2006-11-28
ES2247304T3 (es) 2006-03-01
KR100850818B1 (ko) 2008-08-06

Similar Documents

Publication Publication Date Title
DE60026318D1 (de) Isoxazolin derivate und herbizide, die diese als aktiven bestandteil enthalten
DE60205338D1 (de) Heterocyclische verbindungen und mittel, die die hirnfunktion verbessern und als wirkstoff diese verbindungen enthalten
DE60217322D1 (de) Heterocyclische verbindung und antitumormittel, das diese als wirkstoff enthält
ATE384524T1 (de) Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
DE602004031258D1 (de) Polycyclische mittel zur behandlung von infektione
RU2004104638A (ru) Производное тетразоилоксима и сельскохозяйственный химикат, содержащий его в качестве активного ингредиента
DK1260512T3 (da) Hidtil ukendte, cykliske amidderivater
EA200200661A1 (ru) 3-аминохиназолин-2,4-дионовые антибактериальные агенты
BR9900177A (pt) Inibidores de metaloprotease.
ATE444065T1 (de) 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidon-deriva e als pde-4-hemmer zur behandlung von neurologischen syndromen
ATE377001T1 (de) Pleuromutilinderivate als antimikrobielle mittel
ATE277042T1 (de) Antimikrobielle 4-oxochinolizine mit 2- pyridongerüsten als teilstruktur
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos
ATE525366T1 (de) Benzoxazolderivate und pharmazeutische zubereitungen die diese enthalten
DE69908954D1 (de) Antibakterielle zusammensetzungen
YU33202A (sh) Jedinjenja o-etar oksima i fungicidi za primenu u zemljoradnji i vrtlarstvu
ATE252580T1 (de) Azaindolizinon-derivate und agenzien zur verbesserung der kognitiver fähigkeiten,die dieselben als aktive inhaltstoffe enthalten
DE602006020458D1 (de) Carbonsäureamidverbindung und deren verwendung
ATE381544T1 (de) 1-aryl-4-cycloalk(en)ylpyrazole als antiparasitäre mittel
MX2007005617A (es) Derivados de vinilaminopirazol como pesticidas.
SE1050530T3 (sv) 1-aza-2-alkyl-6-aryl-cykloalkaner anvaendbara som minnesfoerhoejande aemnen
HUP0100134A2 (hu) 1-Metil-5-(alkil-szulfonil/szulfinil vagy tio)-csoporttal szubsztituált pirazolil-pirazol-származékok, előállításuk és alkalmazásuk herbicidként
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament
ATE423109T1 (de) Diaminderivat, herstellungsverfahren und antioxidations-arzneimittel
ATE404548T1 (de) Cyclisches hemiacetalderivat und dessen anwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition